{"id":756,"date":"2016-01-13T14:44:26","date_gmt":"2016-01-13T09:14:26","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=756"},"modified":"2025-05-05T17:06:27","modified_gmt":"2025-05-05T11:36:27","slug":"zemplar-drug-insights-2016-a-delveinsight-report","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report","title":{"rendered":"Zemplar Drug Insights, 2016"},"content":{"rendered":"<p>DelveInsight, the leading market research and consulting company has added new report <strong>Zemplar -Drug Insights, 2016<\/strong> to its portfolio. With this launch DelveInsight now has 400+ Reports on Drug Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed.<\/p>\n<p>The Drug Insight Reports provides client with details on global <strong>Zemplar<\/strong> -Drug Insights, 2016. It comprehensively includes:<\/p>\n<ul>\n<li>Marketed details and the Global API Manufacturers details across the globe along with the location<\/li>\n<li>Total sales estimation along with sales forecast till 2018<\/li>\n<li>Detailed clinical assessment, patent information<\/li>\n<li>SWOT analysis<\/li>\n<\/ul>\n<p>The report on Zemplar -Drug Insights, 2016 will help in evaluating <strong>market scenario<\/strong> and harness opportunities for development by identifying the key <strong>patent expiry details<\/strong> and <strong>exclusivity<\/strong> with respect to Zemplar. In addition to this the detail <strong>sales forecast and SWOT analysis<\/strong> will help companies in finding <strong>collaborations and licensing partners<\/strong>.<\/p>\n<p>DelveInsight is offering the Report at a price of <strong>USD 1000<\/strong> as a single user license,<strong> USD 2000<\/strong> as a site license and <strong>USD 3000<\/strong> as a Global\/Enterprise License.<\/p>\n<p>For more information on API insight Reports, email at <a href=\"mailto:info@delveInsight.com\">info@delveInsight.com<\/a><\/p>\n<p><strong>Contact Us:<\/strong><\/p>\n<p>DelveInsight Business Research<\/p>\n<p>New Delhi-110075, India<\/p>\n<p>+91-11-45689769, +91-9650213330<\/p>\n<p><strong>\u00a0About Us:<\/strong><\/p>\n<p>DelveInsight is a leading Business Consulting and Market Research Firm.\u00a0 We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio. With this launch DelveInsight now has 400+ Reports on Drug Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. The Drug [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[85,86,180,204,216,226,386,594],"industry":[17225],"therapeutic_areas":[17228,17234],"class_list":["post-756","post","type-post","status-publish","format-standard","hentry","category-articles","tag-api-indication-reports","tag-api-intelligence","tag-competitive-landscape","tag-delveinsight","tag-drug","tag-edmf","tag-market-trends","tag-usdmf","industry-pharmaceutical","therapeutic_areas-oncology","therapeutic_areas-rare-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zemplar Drug Insights, 2016 - DelveInsight Business Research LLP<\/title>\n<meta name=\"description\" content=\"DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zemplar Drug Insights, 2016 - DelveInsight Business Research LLP\" \/>\n<meta property=\"og:description\" content=\"DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-01-13T09:14:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T11:36:27+00:00\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zemplar Drug Insights, 2016 - DelveInsight Business Research LLP","description":"DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report","og_locale":"en_US","og_type":"article","og_title":"Zemplar Drug Insights, 2016 - DelveInsight Business Research LLP","og_description":"DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio","og_url":"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-01-13T09:14:26+00:00","article_modified_time":"2025-05-05T11:36:27+00:00","author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report","url":"https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report","name":"Zemplar Drug Insights, 2016 - DelveInsight Business Research LLP","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"datePublished":"2016-01-13T09:14:26+00:00","dateModified":"2025-05-05T11:36:27+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"DelveInsight, the leading market research and consulting company has added new report Zemplar -Drug Insights, 2016 to its portfolio","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/zemplar-drug-insights-2016-a-delveinsight-report"]}]},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">API Indication reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">API Intelligence<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Competitive landscape<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Drug<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">EDMF<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">market trends<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">USDMF<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">API Indication reports<\/span>","<span class=\"advgb-post-tax-term\">API Intelligence<\/span>","<span class=\"advgb-post-tax-term\">Competitive landscape<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">Drug<\/span>","<span class=\"advgb-post-tax-term\">EDMF<\/span>","<span class=\"advgb-post-tax-term\">market trends<\/span>","<span class=\"advgb-post-tax-term\">USDMF<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 10 years ago","modified":"Updated 12 months ago"},"absolute_dates":{"created":"Posted on Jan 13, 2016","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Jan 13, 2016 2:44 pm","modified":"Updated on May 5, 2025 5:06 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=756"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/756\/revisions"}],"predecessor-version":[{"id":31661,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/756\/revisions\/31661"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=756"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=756"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}